Bispecific molecules and uses thereof

Details for Australian Patent Application No. 2001257206 (hide)

Owner Elusys Therapeutics, Inc.

Inventors Himawan, Jeff

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001257206

PCT Pub. Number WO01/80883

Priority 60199903 26.04.00 US; 60244812 01.11.00 US

Filing date 24 April 2001

Wipo publication date 7 November 2001

Acceptance publication date 5 October 2006

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 16/08 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

Event Publications

5 October 2006 Application Accepted

  Published as AU-B-2001257206

8 February 2007 Standard Patent Sealed

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001257207

2001257205